Loading...
Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis
BACKGROUND: Endostatin (ES) inhibits endothelial cell proliferation, migration, invasion, and tube formation. It also shows antiangiogenesis and antitumor activities in several animal models. Endostatin specifically targets tumor vasculature to block tumor growth. Lidamycin (LDM), which consists of...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4016579/ https://ncbi.nlm.nih.gov/pubmed/24128285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-479 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|